VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹648 Cr | ₹601 Cr | ₹556 Cr | ₹600 Cr | ₹548 Cr |
What is the latest Revenue of VENUS REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹648 Cr |
| Mar2024 | ₹601 Cr |
| Mar2023 | ₹556 Cr |
| Mar2022 | ₹600 Cr |
| Mar2021 | ₹548 Cr |
How is Revenue of VENUS REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹648 Cr | 7.72 | |
| Mar2024 | ₹601 Cr | 8.27 | |
| Mar2023 | ₹556 Cr | -7.44 | |
| Mar2022 | ₹600 Cr | 9.50 | |
| Mar2021 | ₹548 Cr | - | |
Compare Revenue of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,297.8 Cr | 2.1% | 11.4% | 192.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 2.1% |
11.4% |
192.2% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses